Crohn's drug study cut short: only 18 patients enrolled
NCT ID NCT03961815
First seen Apr 08, 2026 · Last updated Apr 24, 2026 · Updated 4 times
Summary
This study looked at the long-term safety of the drug brazikumab for people with moderate to severe Crohn's disease. It was designed for patients who had already completed or left an earlier study of the same drug. The study was terminated early and only enrolled 18 participants, so the results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Lincoln, California, 95648, United States
-
Research Site
Clearwater, Florida, 33756, United States
-
Research Site
Kissimmee, Florida, 34741, United States
-
Research Site
Lakeland, Florida, 33813, United States
-
Research Site
Miami, Florida, 33157, United States
-
Research Site
Miami, Florida, 33165, United States
-
Research Site
Miami Lakes, Florida, 33016, United States
-
Research Site
Tampa, Florida, 33626, United States
-
Research Site
Beachwood, Ohio, 44122, United States
-
Research Site
Houston, Texas, 77058, United States
-
Research Site
Hamburg, 20251, Germany
-
Research Site
Rzeszów, 35-302, Poland
-
Research Site
Cape Town, 7500, South Africa
-
Research Site
Plumstead, 7800, South Africa
-
Research Site
Taichung, 40443, Taiwan
Conditions
Explore the condition pages connected to this study.